5,0
8 mar 2019
Dipendente attuale, più di un anno
Pechino, Pechino
Consiglia
Gradimento del CEO
Pronostico commerciale
Vantaggi
No bureaucracy, research team great to work with Great company outlook with pending approval of two drugs this year in China
Svantaggi
Hard to attract top research talent with its research geographical location in Beijing